Info Pulse Now

HOMEcorporatetechentertainmentresearchmiscwellnessathletics

FY2025 EPS Estimates for TerrAscend Decreased by Analyst


FY2025 EPS Estimates for TerrAscend Decreased by Analyst

TerrAscend Corp. (OTCMKTS:TSNDF - Free Report) - Investment analysts at Atb Cap Markets lowered their FY2025 earnings per share (EPS) estimates for shares of TerrAscend in a note issued to investors on Monday, December 9th. Atb Cap Markets analyst F. Gomes now expects that the company will earn ($0.13) per share for the year, down from their prior estimate of ($0.09). Atb Cap Markets currently has a "Hold" rating on the stock. The consensus estimate for TerrAscend's current full-year earnings is ($0.14) per share.

OTCMKTS:TSNDF opened at $0.75 on Wednesday. The company has a current ratio of 1.35, a quick ratio of 0.69 and a debt-to-equity ratio of 0.81. The company has a fifty day moving average price of $0.99 and a 200 day moving average price of $1.23. TerrAscend has a one year low of $0.66 and a one year high of $2.45.

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Before you consider TerrAscend, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TerrAscend wasn't on the list.

While TerrAscend currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

Previous articleNext article

POPULAR CATEGORY

corporate

9808

tech

8831

entertainment

12396

research

5854

misc

13000

wellness

10208

athletics

13170